CERT Latest News, Press Relases and Analysis

All

Press Releases

6 days ago - By: Benzinga - Mentions: NOW CHRW CTSH ZION ...

The Next Wave Of AI Winners? Investors Shift Focus Beyond Nvidia

17 days ago - By: Zacks Investment Research - Mentions: CGEN

Certara, Inc. (CERT) Q3 Earnings Surpass Estimates

17 days ago - By: Certara

Certara Reports Third Quarter 2025 Financial Results

17 days ago - By: Certara

Certara Reports Third Quarter 2025 Financial Results

18 days ago - By: Benzinga - Mentions: STVN PODD AMRK SOLV ...

Earnings Scheduled For November 6, 2025

20 days ago - By: Certara

Certara Automates Scientific Workflows with Phoenix® Cloud

20 days ago - By: Zacks Investment Research - Mentions: IRD

Opus Genetics, Inc. (IRD) May Report Negative Earnings: Know the Trend Ahead of Q3 Release

20 days ago - By: Certara

Certara Automates Scientific Workflows with Phoenix® Cloud

24 days ago - By: Certara

Certara to Participate in Upcoming Investor Conferences

24 days ago - By: Certara

Certara to Participate in Upcoming Investor Conferences

4 months ago - By: Certara

Certara Reports Second Quarter 2025 Financial Results

24 days ago - By: Certara

Certara Expands Biosimulation Market with AI-Driven QSP Platform

24 days ago - By: Certara

Certara Expands Biosimulation Market with AI-Driven QSP Platform

25 days ago - By: Zacks Investment Research - Mentions: ALEC

Analysts Estimate Certara, Inc. (CERT) to Report a Decline in Earnings: What to Look Out for

a month ago - By: Certara

Certara Scientists are Among the Topmost Cited Biopharma Researchers

a month ago - By: Certara

Certara Scientists are Among the Topmost Cited Biopharma Researchers

a month ago - By: Certara

Certara to Report Third Quarter 2025 Financial Results on November 6th, 2025

a month ago - By: Certara

Certara to Report Third Quarter 2025 Financial Results on November 6th, 2025

2 months ago - By: Zacks Investment Research - Mentions: DOCS GEHC

Can Doximity's New AI Suite Drive the Growth It Needs?

3 months ago - By: Certara

Certara Launches Pinnacle 21® Enterprise Plus to Deliver Regulatory Submissions Faster

3 months ago - By: Certara

Certara Launches Pinnacle 21® Enterprise Plus to Deliver Regulatory Submissions Faster

3 months ago - By: Certara

Certara to Participate in Upcoming Investor Conferences

3 months ago - By: Certara

Certara to Participate in Upcoming Investor Conferences

4 months ago - By: The Motley Fool

Certara (CERT) Q2 Revenue Jumps 12%

4 months ago - By: Zacks Investment Research - Mentions: GLUE

Certara, Inc. (CERT) Q2 Earnings Miss Estimates

4 months ago - By: Certara

Certara Reports Second Quarter 2025 Financial Results

4 months ago - By: Certara

Certara Simcyp® Simulator Becomes First and Only Software Platform to Receive EMA Qualification Opinion for PBPK Modeling

4 months ago - By: Certara

Certara Simcyp® Simulator Becomes First and Only Software Platform to Receive EMA Qualification Opinion for PBPK Modeling

4 months ago - By: Certara

Certara Appoints Dr. Chris Bouton as Chief Technology Officer to Advance AI in-silico Drug Discovery and Development Platform

4 months ago - By: Certara

Certara Appoints Dr. Chris Bouton as Chief Technology Officer to Advance AI in-silico Drug Discovery and Development Platform

4 months ago - By: Yahoo Finance - Mentions: SLP CRL

Simulations Plus Sees Weaker Demand Persist, Outlook Softens

5 months ago - By: Certara

Certara to Report Second Quarter 2025 Financial Results on August 6th, 2025

5 months ago - By: Certara

Certara to Report Second Quarter 2025 Financial Results on August 6th, 2025

5 months ago - By: Certara

CERTARA INC (CERT) Stock News

CERT Latest News, Press Relases and Analysis

The Next Wave Of AI Winners? Investors Shift Focus Beyond Nvidia

Certara, Inc. (CERT) Q3 Earnings Surpass Estimates

Certara Reports Third Quarter 2025 Financial Results

Certara Reports Third Quarter 2025 Financial Results

Earnings Scheduled For November 6, 2025

Certara Automates Scientific Workflows with Phoenix® Cloud

Opus Genetics, Inc. (IRD) May Report Negative Earnings: Know the Trend Ahead of Q3 Release

Certara Automates Scientific Workflows with Phoenix® Cloud

Certara to Participate in Upcoming Investor Conferences

Certara to Participate in Upcoming Investor Conferences

Certara Reports Second Quarter 2025 Financial Results

Certara Expands Biosimulation Market with AI-Driven QSP Platform

Certara Expands Biosimulation Market with AI-Driven QSP Platform

Analysts Estimate Certara, Inc. (CERT) to Report a Decline in Earnings: What to Look Out for

Certara Scientists are Among the Topmost Cited Biopharma Researchers

Certara Scientists are Among the Topmost Cited Biopharma Researchers

Certara to Report Third Quarter 2025 Financial Results on November 6th, 2025

Certara to Report Third Quarter 2025 Financial Results on November 6th, 2025

Can Doximity's New AI Suite Drive the Growth It Needs?

Certara Launches Pinnacle 21® Enterprise Plus to Deliver Regulatory Submissions Faster

Certara Launches Pinnacle 21® Enterprise Plus to Deliver Regulatory Submissions Faster

Certara to Participate in Upcoming Investor Conferences

Certara to Participate in Upcoming Investor Conferences

Certara (CERT) Q2 Revenue Jumps 12%

Certara, Inc. (CERT) Q2 Earnings Miss Estimates

Certara Reports Second Quarter 2025 Financial Results

Certara Simcyp® Simulator Becomes First and Only Software Platform to Receive EMA Qualification Opinion for PBPK Modeling

Certara Simcyp® Simulator Becomes First and Only Software Platform to Receive EMA Qualification Opinion for PBPK Modeling

Certara Appoints Dr. Chris Bouton as Chief Technology Officer to Advance AI in-silico Drug Discovery and Development Platform

Certara Appoints Dr. Chris Bouton as Chief Technology Officer to Advance AI in-silico Drug Discovery and Development Platform

Simulations Plus Sees Weaker Demand Persist, Outlook Softens

Certara to Report Second Quarter 2025 Financial Results on August 6th, 2025

Certara to Report Second Quarter 2025 Financial Results on August 6th, 2025

Certara Announces Expansion of Clinical Technology Collaboration with Merck